{"id":"https://openalex.org/W2018185889","doi":"https://doi.org/10.1161/01.cir.91.5.1368","title":"Intermittent Transdermal Nitroglycerin Therapy in Angina Pectoris","display_name":"Intermittent Transdermal Nitroglycerin Therapy in Angina Pectoris","publication_year":1995,"publication_date":"1995-03-01","ids":{"openalex":"https://openalex.org/W2018185889","doi":"https://doi.org/10.1161/01.cir.91.5.1368","mag":"2018185889","pmid":"https://pubmed.ncbi.nlm.nih.gov/7867175"},"language":"en","primary_location":{"id":"doi:10.1161/01.cir.91.5.1368","doi":"https://doi.org/10.1161/01.cir.91.5.1368","is_oa":false,"landing_page_url":"https://doi.org/10.1161/01.cir.91.5.1368","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103410394","display_name":"John O. Parker","orcid":"https://orcid.org/0009-0005-9623-1202","observed_orcids":["https://orcid.org/0009-0005-9623-1202"]},"institutions":[{"id":"https://openalex.org/I204722609","display_name":"Queen's University","ror":"https://ror.org/02y72wh86","country_code":"CA","type":"education","lineage":["https://openalex.org/I204722609"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"John O. Parker","raw_affiliation_strings":["From Queen\u2019s University (J.O.P.), Kingston, Ontario, Canada, and 3M Pharmaceuticals, St Paul, Minn","John O. Parker From Queen's University (J.O.P.), Kingston, Ontario, Canada, and 3M Pharmaceuticals, St Paul, Minn"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Queen\u2019s University (J.O.P.), Kingston, Ontario, Canada, and 3M Pharmaceuticals, St Paul, Minn","institution_ids":["https://openalex.org/I204722609"]},{"raw_affiliation_string":"John O. Parker From Queen's University (J.O.P.), Kingston, Ontario, Canada, and 3M Pharmaceuticals, St Paul, Minn","institution_ids":["https://openalex.org/I204722609"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051793681","display_name":"Mark Amies","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204722609","display_name":"Queen's University","ror":"https://ror.org/02y72wh86","country_code":"CA","type":"education","lineage":["https://openalex.org/I204722609"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Mark H. Amies","raw_affiliation_strings":["From Queen\u2019s University (J.O.P.), Kingston, Ontario, Canada, and 3M Pharmaceuticals, St Paul, Minn","Mark H. Amies From Queen's University (J.O.P.), Kingston, Ontario, Canada, and 3M Pharmaceuticals, St Paul, Minn"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Queen\u2019s University (J.O.P.), Kingston, Ontario, Canada, and 3M Pharmaceuticals, St Paul, Minn","institution_ids":["https://openalex.org/I204722609"]},{"raw_affiliation_string":"Mark H. Amies From Queen's University (J.O.P.), Kingston, Ontario, Canada, and 3M Pharmaceuticals, St Paul, Minn","institution_ids":["https://openalex.org/I204722609"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076575270","display_name":"Ronald W. Hawkinson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204722609","display_name":"Queen's University","ror":"https://ror.org/02y72wh86","country_code":"CA","type":"education","lineage":["https://openalex.org/I204722609"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Ron W. Hawkinson","raw_affiliation_strings":["From Queen\u2019s University (J.O.P.), Kingston, Ontario, Canada, and 3M Pharmaceuticals, St Paul, Minn","Ron W. Hawkinson From Queen's University (J.O.P.), Kingston, Ontario, Canada, and 3M Pharmaceuticals, St Paul, Minn"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Queen\u2019s University (J.O.P.), Kingston, Ontario, Canada, and 3M Pharmaceuticals, St Paul, Minn","institution_ids":["https://openalex.org/I204722609"]},{"raw_affiliation_string":"Ron W. Hawkinson From Queen's University (J.O.P.), Kingston, Ontario, Canada, and 3M Pharmaceuticals, St Paul, Minn","institution_ids":["https://openalex.org/I204722609"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040656972","display_name":"James Heilman","orcid":"https://orcid.org/0000-0002-1347-7700","observed_orcids":["https://orcid.org/0000-0002-1347-7700"]},"institutions":[{"id":"https://openalex.org/I204722609","display_name":"Queen's University","ror":"https://ror.org/02y72wh86","country_code":"CA","type":"education","lineage":["https://openalex.org/I204722609"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"James M. Heilman","raw_affiliation_strings":["From Queen\u2019s University (J.O.P.), Kingston, Ontario, Canada, and 3M Pharmaceuticals, St Paul, Minn","James M. Heilman From Queen's University (J.O.P.), Kingston, Ontario, Canada, and 3M Pharmaceuticals, St Paul, Minn"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Queen\u2019s University (J.O.P.), Kingston, Ontario, Canada, and 3M Pharmaceuticals, St Paul, Minn","institution_ids":["https://openalex.org/I204722609"]},{"raw_affiliation_string":"James M. Heilman From Queen's University (J.O.P.), Kingston, Ontario, Canada, and 3M Pharmaceuticals, St Paul, Minn","institution_ids":["https://openalex.org/I204722609"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053894841","display_name":"Andrina J. Hougham","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204722609","display_name":"Queen's University","ror":"https://ror.org/02y72wh86","country_code":"CA","type":"education","lineage":["https://openalex.org/I204722609"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Andrina J. Hougham","raw_affiliation_strings":["From Queen\u2019s University (J.O.P.), Kingston, Ontario, Canada, and 3M Pharmaceuticals, St Paul, Minn","Andrina J. Hougham From Queen's University (J.O.P.), Kingston, Ontario, Canada, and 3M Pharmaceuticals, St Paul, Minn"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Queen\u2019s University (J.O.P.), Kingston, Ontario, Canada, and 3M Pharmaceuticals, St Paul, Minn","institution_ids":["https://openalex.org/I204722609"]},{"raw_affiliation_string":"Andrina J. Hougham From Queen's University (J.O.P.), Kingston, Ontario, Canada, and 3M Pharmaceuticals, St Paul, Minn","institution_ids":["https://openalex.org/I204722609"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113193302","display_name":"Mark C. Vollmer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204722609","display_name":"Queen's University","ror":"https://ror.org/02y72wh86","country_code":"CA","type":"education","lineage":["https://openalex.org/I204722609"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Mark C. Vollmer","raw_affiliation_strings":["From Queen\u2019s University (J.O.P.), Kingston, Ontario, Canada, and 3M Pharmaceuticals, St Paul, Minn","Mark C. Vollmer From Queen's University (J.O.P.), Kingston, Ontario, Canada, and 3M Pharmaceuticals, St Paul, Minn"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Queen\u2019s University (J.O.P.), Kingston, Ontario, Canada, and 3M Pharmaceuticals, St Paul, Minn","institution_ids":["https://openalex.org/I204722609"]},{"raw_affiliation_string":"Mark C. Vollmer From Queen's University (J.O.P.), Kingston, Ontario, Canada, and 3M Pharmaceuticals, St Paul, Minn","institution_ids":["https://openalex.org/I204722609"]}]},{"author_position":"last","author":{"id":null,"display_name":"Richard R. Wilson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204722609","display_name":"Queen's University","ror":"https://ror.org/02y72wh86","country_code":"CA","type":"education","lineage":["https://openalex.org/I204722609"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Richard R. Wilson","raw_affiliation_strings":["From Queen\u2019s University (J.O.P.), Kingston, Ontario, Canada, and 3M Pharmaceuticals, St Paul, Minn","Richard R. Wilson From Queen's University (J.O.P.), Kingston, Ontario, Canada, and 3M Pharmaceuticals, St Paul, Minn"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Queen\u2019s University (J.O.P.), Kingston, Ontario, Canada, and 3M Pharmaceuticals, St Paul, Minn","institution_ids":["https://openalex.org/I204722609"]},{"raw_affiliation_string":"Richard R. Wilson From Queen's University (J.O.P.), Kingston, Ontario, Canada, and 3M Pharmaceuticals, St Paul, Minn","institution_ids":["https://openalex.org/I204722609"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I204722609"],"apc_list":null,"apc_paid":null,"fwci":5.7759,"has_fulltext":false,"cited_by_count":86,"citation_normalized_percentile":{"value":0.96299959,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"91","issue":"5","first_page":"1368","last_page":"1374"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13381","display_name":"Heart rate and cardiovascular health","score":0.6567000150680542,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13381","display_name":"Heart rate and cardiovascular health","score":0.6567000150680542,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10155","display_name":"Nitric Oxide and Endothelin Effects","score":0.3188000023365021,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10193","display_name":"Coronary Interventions and Diagnostics","score":0.00419999985024333,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/transdermal-nitroglycerin","display_name":"transdermal nitroglycerin","score":0.9350000023841858},{"id":"https://openalex.org/keywords/angina","display_name":"angina pectoris","score":0.9950000047683716},{"id":"https://openalex.org/keywords/antianginal-effect","display_name":"antianginal effect","score":0.6480000019073486},{"id":"https://openalex.org/keywords/anti-ischemic-effect","display_name":"anti-ischemic effect","score":0.8759999871253967},{"id":"https://openalex.org/keywords/nitrate-tolerance","display_name":"nitrate tolerance","score":0.8870000243186951},{"id":"https://openalex.org/keywords/rebound","display_name":"rebound","score":0.5799999833106995},{"id":"https://openalex.org/keywords/dose-levels","display_name":"dose levels","score":0.5189999938011169},{"id":"https://openalex.org/keywords/st-segment-depression","display_name":"ST-segment depression","score":0.9210000038146973},{"id":"https://openalex.org/keywords/duration-of-action","display_name":"duration of action","score":0.5199999809265137}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9785106182098389},{"id":"https://openalex.org/C2776915253","wikidata":"https://www.wikidata.org/wiki/Q3221044","display_name":"Nitroglycerin (drug)","level":2,"score":0.8961172103881836},{"id":"https://openalex.org/C2778425758","wikidata":"https://www.wikidata.org/wiki/Q180762","display_name":"Angina","level":3,"score":0.7985818982124329},{"id":"https://openalex.org/C205679159","wikidata":"https://www.wikidata.org/wiki/Q3375179","display_name":"Transdermal","level":2,"score":0.5556215047836304},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.5001814365386963},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4701421856880188},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40723809599876404},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.16425484418869019},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.14351287484169006}],"mesh":[{"descriptor_ui":"D000279","descriptor_name":"Administration, Cutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000787","descriptor_name":"Angina Pectoris","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004361","descriptor_name":"Drug Tolerance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004562","descriptor_name":"Electrocardiography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005080","descriptor_name":"Exercise Test","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005996","descriptor_name":"Nitroglycerin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005996","descriptor_name":"Nitroglycerin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017079","descriptor_name":"Exercise Tolerance","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017202","descriptor_name":"Myocardial Ischemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1161/01.cir.91.5.1368","doi":"https://doi.org/10.1161/01.cir.91.5.1368","is_oa":false,"landing_page_url":"https://doi.org/10.1161/01.cir.91.5.1368","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},{"id":"pmid:7867175","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7867175","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W1896433483","https://openalex.org/W1968391779","https://openalex.org/W1996972928","https://openalex.org/W2023002026","https://openalex.org/W2039353933","https://openalex.org/W2039733992","https://openalex.org/W2043275348","https://openalex.org/W2120983965","https://openalex.org/W2168354280","https://openalex.org/W2260925657","https://openalex.org/W2431610244"],"related_works":["https://openalex.org/W2022560594","https://openalex.org/W2004154190","https://openalex.org/W2083742574","https://openalex.org/W2260925657","https://openalex.org/W2415246108","https://openalex.org/W2059564666","https://openalex.org/W2039353933","https://openalex.org/W2147783879","https://openalex.org/W2024104121","https://openalex.org/W2002031421"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,30,101],"objectives":[2],"of":[3,14,18,36,48,62,79,92,94,97,99,107,110,115,120,218,243,248],"this":[4],"study":[5,31,83,102,126,194],"were":[6,149],"to":[7,50,69,86,153,172,188,205],"assess":[8],"the":[9,34,60,76,88,105,108,113,118,192,200,210],"antianginal":[10],"and":[11,38,90,117,146,230],"anti-ischemic":[12,232],"effects":[13,233],"three":[15],"dose":[16],"levels":[17],"transdermal":[19,41,224],"nitroglycerin":[20,42,177,225],"patches":[21],"applied":[22],"for":[23,27,75,234],"12":[24,51,154,189,235],"hours":[25,52,155,190,236],"daily":[26],"30":[28,241],"days.":[29],"also":[32,103],"assessed":[33],"development":[35,114],"tolerance":[37,219,250],"rebound.":[39,121,221],"Intermittent":[40,223],"therapy":[43,226],"with":[44,136,166,181],"a":[45,95,128,161],"patch-free":[46],"period":[47,61,78],"10":[49],"each":[53,176],"day":[54],"has":[55],"documented":[56],"clinical":[57],"benefits":[58],"during":[59],"patch":[63,80,157,178,238],"application,":[64,239],"but":[65],"studies":[66],"have":[67],"failed":[68],"clearly":[70],"document":[71],"prolonged":[72],"exercise":[73,138,228],"duration":[74,91,229],"entire":[77],"application.":[81,158],"This":[82,125],"was":[84,127,160,215],"designed":[85],"evaluate":[87],"efficacy":[89,197,212],"action":[93],"range":[96],"doses":[98],"nitroglycerin.":[100],"permitted":[104],"assessment":[106],"maintenance":[109],"initial":[111],"effects,":[112],"tolerance,":[116],"presence":[119],"METHODS":[122],"AND":[123],"RESULTS:":[124],"multicenter,":[129],"randomized,":[130],"double-blind,":[131],"placebo-controlled":[132],"parallel":[133],"design":[134],"trial":[135],"treadmill":[137,169],"tests":[139],"at":[140,183],"days":[141,242],"0,":[142],"1,":[143],"7,":[144],"15,":[145],"30.":[147],"Tests":[148],"carried":[150],"out":[151],"up":[152,187],"after":[156,237],"There":[159,214],"statistically":[162],"significant":[163,246],"treatment":[164],"effect":[165],"increases":[167,227],"in":[168,175,203],"walking":[170],"time":[171,185,204],"moderate":[173],"angina":[174],"group":[179],"compared":[180],"placebo":[182],"various":[184],"points":[186],"throughout":[191,240],"30-day":[193],"period.":[195],"Secondary":[196],"parameters,":[198],"including":[199],"consistent":[201],"increase":[202],"1-mm":[206],"ST-segment":[207],"depression,":[208],"supported":[209],"primary":[211],"results.":[213],"no":[216],"evidence":[217,247],"or":[220,251],"CONCLUSIONS:":[222],"maintains":[231],"therapy,":[244],"without":[245],"nitrate":[249],"rebound":[252],"phenomena.":[253]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}